Article Navigation

Back To Main Page


 

More Articles

The Risk of recurrence in prostate cancer


by: Fritz Frei

Prostate cancer disease

Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high.

Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease.

1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent.

2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary.

3. The Decisions about the best management of prostate cancer can be very complex and depend upon the:

- Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly)
- The impact that treatment can have on quality of life, including sexual activity
- Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory)
- Age and general health of the patients at diagnosis
- Patient’s preference for treatment
- PSA at diagnosis

4. The treatment options for prostate cancer are:

- Deferred treatment often called ‘watchful waiting’ or 'active surveillance'
- Surgery – Radical Prostatectomy
- Radiotherapy – External Beam and/or Brachytherapy
-Hormonal (endocrine) therapy – Androgen Ablation e.g. anti-androgens, medical castration (LHRHa) or surgical castration
- Chemotherapy
- Palliative Therapy e.g. chemotherapy
- Investigational Therapies

Prostate Cancer Recurrence Rates ***

Prostate cancer is now detected at earlier stages due to heightened awareness and improved screening techniques. Despite definitive therapy, cancer cells may remain and can go undetected for years until they develop into metastatic disease. The risk of recurrence is high, suggesting there is a need to improve treatment approaches. Therefore, it is important to predict pathological stage and risk of disease recurrence early, so that appropriate treatment and/or monitoring can be initiated. The result's of all new treatments will bring us in the future the chance of a lower prostate recurrance.

**You can inform you about the recurrence Rates on:
http://www.prostateline.com/prostatelinehcp/9898_15850_8_0_0.aspx

This gives you an overview with a study case – and the results.

Health-Service-Online
Admin Fritz

http://www.cancer-info.info




Latest Cancer News:



Cancer teen hits £1m charity target


A teenage blogger with terminal cancer raises more than £1m for charity after posting his final message to followers. Cancer Care Ontario finds thousands of cancer cases caused by alcohol consumption


Ontarians unaware of the cancer risks associated with drinking TORONTO, April 22, 2014 /CNW/ - As many as 3,000 new cancer cases each year in Ontario can be attributed to alcohol consumption, according to a report released today by Cancer Care Ontario (CCO). The report, entitled Cancer Risk Factors in Ontario: Alcohol, is part of a series that examines cancer risk factors facing Ontarians. "Many ... Scientists identify cancer specific cell for potential treatment of gastric cancer


( National University of Singapore ) A team of scientists led by a researcher from the Cancer Science Institute of Singapore at the National University of Singapore has identified the cancer specific stem cell which causes gastric cancer. This discovery opens up the possibility of developing new drugs for the treatment of this disease and other types of cancers. Cancer Treatment: How 'Dustman' Proteins Can Sweep Up Cancerous Cells


Cancer researchers have discovered a new 'dustman' role for a molecule that helps a drug kill cancer cells. The new findings point to a possible test that could identify patients who would be most responsive to a new class of cancer drugs and also those who might develop resistance, as well as suggesting new approaches to discovering more effective drugs. The study, by Cancer Research UK-funded ... Breast cancer drug Kadcyla 'too expensive' for NHS


A BREAST cancer drug currently being tested at a local hospital has been rejected for NHS funding - because it costs too much. Kadcyla, an antibody drug conjugate made by pharmaceutical company Roche, is estimated to give some patients with advanced cancers another six months of life and help to cut the risk of the illness returning. University Hospital of North Staffordshire (UHNS) became the ... Bone Cancer Global Clinical Trials Review, H1, 2014


LONDON, April 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Bone Cancer Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/drug_discovery/bone_cancer_global_clinical_trials_review_h1_2014.html ... Medline to Deliver Significant Savings as Cancer Treatment Centers of America?s New Prime Vendor Medical Supply ...


Cancer Treatment Centers of America® , a leading provider of innovative cancer care for patients living with complex and advanced-stage disease, recently selected Medline Industries, Inc. Breast cancer drug is too expensive for the NHS: Nice


A breast cancer drug that can extend life by almost six months has been turned down for use on the NHS because it is too expensive. Scientists Identify Cancer Specific Cell for Potential Targeted Treatment of Gastric Cancer


A team of scientists led by a researcher from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has identified the cancer specific stem cell which causes gastric cancer. This discovery opens up the possibility of developing new drugs for the treatment of this disease and other types of cancers. Breast Cancer Drug Blocked By Health Watchdog, Deemed Too Expensive For NHS


A new Herceptin-style breast cancer drug, which costs £90,000 but can prolong lives by almost six months is to be turned down from routine NHS access under draft guidance issued by a health watchdog. Kadcyla is being criticised as "not effective enough" to justify the cost to the NHS, according to the National Institute for Health and Care Excellence (Nice). The watchdog, responsible for ... Breast cancer drug turned down for NHS use due to high cost - The Guardian


News Image
The Guardian

News Image
Breast cancer drug turned down for NHS use due to high cost
The Guardian
The drug, called Kadcyla (generic name trastuzumab emtansine), is already being paid for through the dedicated Cancer Drugs Fund set up by the government. A decision was made to fund it so that women with advanced breast cancer could receive it ...
High-fat diets linked to some types of breast cancerReuters
Breast cancer drug is too expensive for the NHS: NiceTelegraph.co.uk
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites ...FiercePharma
Yahoo News
all 79 news articles »
British teen with terminal cancer says goodbye on Facebook - New York Daily News


News Image
The Independent

News Image
British teen with terminal cancer says goodbye on Facebook
New York Daily News
He set out to raise 10,000 pounds ($16,820) for the Teenage Cancer Trust, a charity that supports young cancer patients. He and his followers smashed that goal, raising more than 660,900 pounds (more than $1.1 million) toward his new goal of generating ...
Teen blogger dying of cancer writes 'final thumbs up'USA TODAY (blog)
Stephen Sutton: Terminally-ill teenage cancer sufferer raises £1m for charity ...The Independent
Meetings with teenage cancer sufferer Stephen Sutton left me a better personMirror.co.uk
Metro -ITV News -The West Australian
all 75 news articles »
Tony Gwynn takes time off from San Diego State as cancer treatments continue - SportingNews.com


News Image
Yahoo Sports

News Image
Tony Gwynn takes time off from San Diego State as cancer treatments continue
SportingNews.com
Hall of Famer Tony Gwynn is taking time off as head baseball coach at San Diego State as he continues treatments for cancer, FOX 5 San Diego reports. Gwynn had surgery to remove a malignant tumor from the inside of his right cheek in February 2012.
Tony Gwynn on medical leave because of ongoing cancer treatmentsLos Angeles Times
Tony Gwynn takes time from SDSUESPN

all 36 news articles »
Buffalo Bills Publish Report That Head Coach Has "BLANK TYPE OF CANCER" - Deadspin


News Image
FanSided

News Image
Buffalo Bills Publish Report That Head Coach Has "BLANK TYPE OF CANCER"
Deadspin
The Buffalo Bills published an article which reported head coach Doug Marrone had cancer. Though Marrone may have planned to announce his cancer, the story looks to be prematurely published, since "BLANK TYPE OF CANCER" is still in the dek.
Bills website posts, then deletes, article announcing that coach Doug Marrone ...NBCSports.com
Buffalo Bills website reports Doug Marrone has cancer, removes article ...Awful Announcing
Buffalo Bills website publishes, then removes report that Doug Marrone has cancerThe Post-Standard
FanSided -Buffalo News -WIVB
all 125 news articles »
Mindy Taylor Cancer Scam Bilked Donors Of $21000, Police Say - Huffington Post


News Image
New York Daily News

News Image
Mindy Taylor Cancer Scam Bilked Donors Of $21000, Police Say
Huffington Post
An Ohio woman who raised more than $21,000 to help her fight cancer turned out not to have the disease at all, according to police. Now, 35-year-old Mindy Taylor is facing felony theft charges for allegedly bilking donors who thought they were joining ...
Ohio mother charged after allegedly faking cancer and raising thousands in ...New York Daily News
Woman fakes cancer; tricks friends, neighbors into donating thousands of dollarsThe Post-Standard
Chillicothe, Ohio duped by mother who raised thousands pretending to have ...Daily Mail
The Inquisitr -Washington Post -Fashion Times
all 14 news articles »
Can anti-inflammatory foods help reduce cancer risk? - Fox News



News Image
Can anti-inflammatory foods help reduce cancer risk?
Fox News
Chronic inflammation has started to become a buzzword in the health world as research builds indicating that it may be the cause of many serious illnesses, from heart disease to cancer. According to the National Institutes of Health there is direct ...

and more »
'Survivor' singer helps spread hope to kids with cancer - Fox News



News Image
'Survivor' singer helps spread hope to kids with cancer
Fox News
Hyundai Motor America and its dealers have been fighting the war on pediatric cancer for more than 15 years, and to date, they have raised more than $86 million in research funds through their non-profit organization, Hyundai Hope on Wheels. Fox News' ...

Parkinson's Drug Could Help Prevent Breast Cancer In High-Risk Women - Huffington Post



News Image
Parkinson's Drug Could Help Prevent Breast Cancer In High-Risk Women
Huffington Post
One drug, called benserazide, is currently used for Parkinson's disease, and in studies it reduced the formation of breast tumors in mice that had been implanted with cancer cells containing the BRCA1 gene mutation. All of the mice that did not receive ...
Trabectedin demonstrated activity in germline BRCA-mutated breast cancerHealio

all 5 news articles »
Until There's a Cure: 21 Ways Longhorns Fight Cancer - University of Texas at Austin News


News Image
University of Texas at Austin News

News Image
Until There's a Cure: 21 Ways Longhorns Fight Cancer
University of Texas at Austin News
It's why she formed a cancer-focused working group with fellow UT researchers Amy Brock (biomedical engineering), Carla Van Den Berg (pharmacy) and Vernita Gordon (physics). They are meeting to learn more about each other's work and review other ...

FDA approves new Eli Lilly and Co. drug to treat stomach cancer - Indianapolis Star


News Image
Medical Marketing and Media

News Image
FDA approves new Eli Lilly and Co. drug to treat stomach cancer
Indianapolis Star
The U.S. Food and Drug Administration approved Cyramza to treat patients with advanced stomach cancer. The approval is a key win for the Indianapolis drug maker, which is banking on new drugs to replace sales from several of its key drugs that lost ...
FDA approves new drug for stomach cancerFox News
FDA approves Cyramza for stomach cancerFDA.gov
Lilly's Gastric Cancer Drug Wins Approval From U.S. FDABloomberg
Fox 59 -FierceBiotech
all 73 news articles »

 



Home | Resource Links | Contact Us
Copyright © 2006 CancerAdvice.org